Application
영진바이오크롬의 자료를 제공합니다.
| 번호 | 분류 | 제목 | 작성일 | 첨부파일 |
|---|---|---|---|---|
| 49 | 의약품 | Rebamipide (KP, 2-Amino-3- 2[(1H)-quinolinone-4-yl] propionate·2HCl) | 2025-01-10 | |
| 48 | 의약품 | Naproxen Sodium Tablets (KP, Assay) | 2025-01-10 | |
| 47 | 의약품 | Simvastatin (USP, Impurity) | 2025-01-10 | |
| 46 | 의약품 | Betadex (USP, Assay) | 2025-01-10 | |
| 45 | 의약품 | Pseudoephedrine HCl + Triprolidine HCl tablets (USP, Assay) | 2025-01-10 | |
| 44 | 의약품 | Esomeprazole Magnesium Delayed-Release Capsules (USP, Impurity) | 2025-01-10 | |
| 43 | 의약품 | L-Arginine-L-aspartate solution (KP, Assay) | 2025-01-10 | |
| 42 | 의약품 | Olopatadine Hydrochloride (USP, Limit of Early Eluting Impurities) | 2025-01-10 | |
| 41 | 의약품 | Olopatadine Hydrochloride (USP, Limit of Late Eluting Impurities) | 2025-01-10 | |
| 40 | 의약품 | Olopatadine Hydrochloride (USP, Assay) | 2025-01-10 | |
| 39 | 의약품 | Gabapentin Tablets (Dissolution) | 2025-01-10 | |
| 38 | 의약품 | Buspirone HCl Tablets(USP, Related substances) | 2025-01-10 | |
| 37 | 의약품 | Buspirone HCl Tablets (USP, Assay) | 2025-01-10 | |
| 36 | 의약품 | Cisplatin injection (Assay) | 2025-01-10 | |
| 35 | 의약품 | Chlorpheniramine maleate (KP, Related substances) | 2025-01-10 |